Growth and Adiposity in Newborns: The Influence of Prenatal Docosahexaenoic Acid (DHA) Supplementation

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

254 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-11-01

Study Completion Date

2022-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to learn if participants in the ADORE study (NCT02626299), who took a DHA supplement during pregnancy, see favorable body fat in their infants from birth to 24 months, and if excessive or appropriate weight gain during pregnancy impacts this result.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prenatal DHA and Neurofunctional Development

NCT02709239

Use and Dose of Prenatal DHA Supplementation

COMPLETED NA

Effects of Docosahexaenoic Acid (DHA) on Fetal Cardiac Outcomes

NCT01007110

Pregnancy

COMPLETED PHASE3

DHA Supplementation for Lactating Mothers

NCT01732874

Docosohexaenoic Acid Supplementation of Mothers to

COMPLETED PHASE1/PHASE2

Early DHA Supplementation in Very Low Birth Weight Infants

NCT03192839

Prematurity

COMPLETED NA

Synergistic Activity of Human Milk Nutrients and Infant Cognition

NCT03838536

Breastfeeding, Exclusive

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy; Nutritional Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ADORE- 200 mg/day

Participants enrolled in the ADORE study that were randomly assigned to the 200 mg/day group that consented to participate in ADORE-GAINS.

No interventions assigned to this group

ADORE - 1000 mg/day

Participants enrolled in the ADORE study that were randomly assigned to the 1000 mg/day group that consented to participate in ADORE-GAINS.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Agree to consume study capsules and a typical prenatal supplement of 200 mg DHA
* Available by telephone

Exclusion Criteria

* Expecting multiple infants
* Gestational age at baseline \<12 weeks or \>20 weeks
* Unable or unwilling to agree to consume capsules until delivery
* Unwilling to discontinue use of another prenatal supplement with DHA that contains ≥ 200 mg DHA
* Women with allergy to any component of DHA product (including algae), soybean oil or corn oil

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes